Evaluation of Practice of Prescription of the Corticotherapy in the Department of Internal Medicine of the University Hospital of Point G from 2009 to 2013
- 1 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
- 2 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
- 3 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
- 4 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
- 5 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
- 6 Department of Cardiology, University Hospital of Point G, Bamako, Mali
- 7 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
- 8 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
- 9 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
- 10 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
- 11 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
- 12 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
- 13 Department of Internal Medecine, University Hospital of Point G, Bamako, Mali
Abstract
Introduction: It is estimated that about 0.2% to 0.5% of French populations received a long-term systemic corticosteroid therapy. In Mali, from March, 2007 to February, 2008, in National Center for Disease Control and Prevention, 19.2% of hospitalized patients (24/125) received long-term corticosteroid therapy. Until now, the department of internal medicine of the university hospital of Point G hasn’t done any research on the corticosteroid therapy specially. Therefore, we initiated this work to evaluate our practice of prescription of corticosteroid. The target of the study was to evaluate practical activity of prescription of corticosteroid of internal medicine. Methods: Based on all hospitalized patient materials of the department of internal medicine of Point G regional university central hospital during January 2009-December 2013, we initiated this retrospective and descriptive study. This study was based on all hospitalized patients receiving corticosteroid in the time of researching, without distinguishing their sex or age. Results: During the period of study, the department of internal medicine of point G regional central hospital had received 2155 patients; 64 were eligible: prevalence of 2.97%. Most patients were female, accounting for 87.5% with a sex-ratio of 0.14. The average age of our patients was 39.11 ± 16.92 years, ranging from 14 to 97 years. Physicians enrolled in the study Specialized Diploma (DES) and Internal represented 79.7% of prescribers. As pretreatment assessment, only 2 patients (3.12%) had carried out all of the standard balance (NFS, electrolytes, calcium, blood glucose and serum protein). The most common glucocorticoide was prednisone. Solid tumors represented 31.25% (20 cases) of the diseases treated, followed by systemic lupus erythematosus with 15.62% (10 cases). In addition, there are two cases of adrenals insufficiency (3.1%). In Point G internal medicine, pre-therapy evaluation and methods about corticosteroids therapy were insufficient and different.
- Fardet, L., Hanslik, T., Blanchon, T., Perdoncini-Roux, A., Kettaneh, A., Tiev, K.P., Turbelin, C., Dorleans, Y., Cabane, J., et al. (2008) Adjuvant Measures to Long-Term Systemic Corticosteroid Therapy: Practice Description of French Physicians. La Revue de Médecine Interne, 29, 975-980. https://doi.org/10.1016/j.revmed.2008.04.001
- Fardet, L., Petersen, I. and Nazareth, I. (2011) Description of Prescriptions for Oral Corticosteroids in the General Population. La Revue de Médecine Interne, 32, 594-599. https://doi.org/10.1016/j.revmed.2011.02.022
- Keita, A.C.F. (2011) Evaluation of the Cost of Long-Term General Corticosteroids in the Dermatology Department of the National Center for Disease Control and Prevention (CNAM). Essay, Med, Bamako, No. 11-M-303.
- Larbre, J.P. and Llorca, G. (1999) Corticosteroids: Use Principles and Rules. La Revue du Praticien, 49, 893-900.
- Bertherat, J. (2002) Corticotherapy and Adrenal Function. Ency Med Chir Nutrition 10-015-A-20, 6 p.
- Dussauze, H., Bourgault, I., Doleris, L.-M., Prinseau, J., Baglin, A. and Hanslik, T. (2007) Systemic Corticosteroids and Infectious Risk. La Revue de Médecine Interne, 28, 841-851. https://doi.org/10.1016/j.revmed.2007.05.030